Jacobs Levy Equity Management, Inc Surface Oncology, Inc. Transaction History

Jacobs Levy Equity Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.17 - $2.33 $85,880 - $171,026	-73,402 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.4 - $2.84 $28,977 - $58,782	-20,698 Reduced 22.0%	73,402 $104,000
Q2 2019 Aug 13, 2019	BUY	$2.75 - $4.89 $6,875 - $12,225	2,500 Added 2.73%	94,100 $265,000
Q1 2019 May 14, 2019	BUY	$4.11 - $5.88 $232,075 - $332,020	56,466 Added 160.72%	91,600 $437,000
Q4 2018 Feb 14, 2019	BUY	$3.65 - $10.69 $83,585 - $244,801	22,900 Added 187.18%	35,134 $149,000
Q3 2018 Nov 14, 2018	BUY	$8.92 - $17.83 $109,127 - $218,132	12,234 New	12,234 $134,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.